treatment

Empowering Youth: Students Learn About Cancer Detection, Treatment, and Hope

Manipal Hospital Old Airport Road Raises Cancer Awareness with 'Breaking Barriers, Building Awareness' BENGALURU, India, Dec. 24, 2024 /PRNewswire/ --…

8 hours ago

Empowering Youth: Students Learn About Cancer Detection, Treatment, and Hope

Manipal Hospital Old Airport Road Raises Cancer Awareness with 'Breaking Barriers, Building Awareness' BENGALURU, India, Dec. 24, 2024 /PRNewswire/ --…

18 hours ago

Empowering Youth: Students Learn About Cancer Detection, Treatment, and Hope

Manipal Hospital Old Airport Road Raises Cancer Awareness with 'Breaking Barriers, Building Awareness' BENGALURU, India, Dec. 24, 2024 /PRNewswire/ --…

1 day ago

Adaptive Biotechnologies Announces New Data at the 66th ASH Annual Meeting Highlighting Advances in MRD Testing with clonoSEQ and Its Impact on Blood Cancer Treatment Decisions

New data demonstrate the actionability of clonoSEQ for tailoring treatment decisions in patients with MCL, CLL, MM and ALL Studies…

3 weeks ago

BioAge Labs Announces Discontinuation of STRIDES Phase 2 Clinical Trial Evaluating Azelaprag in Combination with Tirzepatide for the Treatment of Obesity

December 06, 2024 16:35 ET | Source: BioAge Labs, Inc. Decision follows observations of liver transaminitis without clinically significant symptoms…

3 weeks ago

Theriva Biologics Announces U.S. FDA Guidance on Design of Phase 3 Study of VCN-01 for the Treatment of Metastatic Pancreatic Cancer

December 05, 2024 08:00 ET | Source: Theriva Biologics, Inc. ROCKVILLE, Md., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Theriva™ Biologics…

3 weeks ago

Bharath Advanced Therapeutics (BAT) advancing Cancer treatment in India by setting new benchmarks in affordable and transformational care

HYDERABAD, India, Dec. 3, 2024 /PRNewswire/ -- Bharath Advanced Therapeutics (BAT), as a key organiser of Cancer NEXT 2024 alongside…

3 weeks ago

Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024

– Petosemtamab 1500 mg monotherapy phase 2 interim data continues to demonstrate clinically meaningful activity in 2L+ HNSCC – Conference…

3 weeks ago

Zevra Therapeutics Announces U.S. Commercial Availability of MIPLYFFA (arimoclomol) for Treatment of Niemann-Pick Disease Type C

November 21, 2024 16:51 ET | Source: Zevra Therapeutics MIPLYFFA, the first FDA-approved treatment for Niemann-Pick disease type C, is…

1 month ago

Numab Therapeutics and Kaken Pharmaceutical Enter Collaborationand Option Agreement for Multi-specific Antibody ND081 for Treatment of Inflammatory Bowel Disease

Numab to receive R&D funding for the preclinical development of ND081 Kaken Pharmaceutical receives an option to in-license ND081 in…

1 month ago